{
  "_id": "68024a013ccffd1c7912c7f3",
  "ipo_id": "2024_senores_pharmaceuticals_limited_ipo",
  "__v": 0,
  "_metadata": {
    "sectionsAvailable": {
      "basicDetails": true,
      "tentativeSchedule": true,
      "lotSize": true,
      "timeline": false,
      "kpi": true,
      "financials": true,
      "promoterHolding": true,
      "objectives": false,
      "about": true,
      "subscriptionStatus": true,
      "contactDetails": true,
      "registrarDetails": true,
      "leadManagers": true,
      "listingDetails": true,
      "listingDayTrading": true,
      "faqs": true,
      "recommendationSummary": true,
      "prospectusLinks": true,
      "reservation": true,
      "anchorInvestors": true
    },
    "scrapedAt": "2025-04-18T12:15:30.598Z",
    "sourceUrl": "https://www.chittorgarh.com/ipo/senores-pharmaceuticals-ipo/1943/"
  },
  "about": {
    "details": "<p>Incorporated in December 2017, Senores Pharmaceuticals Limited develops and manufactures a range of pharmaceutical products primarily for the regulated markets of the US, Canada, and the UK, while also serving emerging markets.</p>\n<p>The company's product portfolio consists of Amphetamine Sulfate Tablets, Hydroxychloroquine Sulfate Tablets, Ketoconazole Tablets, Butalbital, Acetaminophen and Caffeine Capsules, Mexiletine Hydrochloride Capsules, Ketorolac Tromethamine Tablets, Diclofenac Potassium Tablets, Diclofenac Potassium Tablets, Nicardipine Hydrochloride Capsules, Escitalopram Tablets, Prochlorperazine Maleate Tablets USP, Terazosin Capsules USP, Morphine Sulfate Tablets, Methadone Hydrochloride Tablets, Cyclobenzaprine Hydrochloride Tablets, Irbesartan Tablets, Risperidone Tablets Topiramate Capsules, and Ivermectin Tablets for regulated markets.</p>\n<p>As of September 30, 2024, the company has launched 55 products in key therapeutic areas, including antibiotics and anti-fungal treatments. They have established partnerships with distributors and hospitals across several states in India.</p>\n<p>As of September 30, 2024, the company operates three dedicated R&amp;D facilities in India and the US.</p>\n<p>The company operates in Emerging Markets across 43 countries and manufactures critical care injectables and APIs.</p>\n<p>The company's manufacturing unit is situated in Ahmedabad, Gujrat.</p>\n<p><strong>Competitive Strength</strong></p>\n<ol>\n<li>The company serves the US, Canada, and the UK regulated markets with its US FDA-approved manufacturing facility.</li>\n<li>A unique product portfolio tailored for regulated markets developed in a brief period.</li>\n<li>Long-term marketing agreements with pharmaceutical companies in the US, Canada, and the United Kingdom regulated markets.</li>\n<li>\n<div>Presence in the Emerging Markets with a product portfolio, including speciality or complex products.</div>\n</li>\n<li>Robust R&amp;D capabilities driving our differentiated portfolio of products.</li>\n<li>Experieced Management Team</li>\n</ol>"
  },
  "additionalTables": [
    {
      "heading": "Senores Pharmaceuticals IPO Details",
      "sanitizedHeading": "senores_pharmaceuticals",
      "headers": [
        "Application Category",
        "Maximum Bidding Limits",
        "Bidding at Cut-off Price Allowed"
      ],
      "rows": [
        [
          "Only RII",
          "Up to Rs 2 Lakhs",
          "Yes"
        ],
        [
          "Only sNII",
          "Rs 2 Lakhs to Rs 10 Lakhs",
          "No"
        ],
        [
          "Only bNII",
          "Rs 10 Lakhs to NII Reservation Portion",
          "No"
        ],
        [
          "Only employee",
          "Up to Rs 2 Lakhs",
          "Yes"
        ],
        [
          "Employee + RII/NII",
          "Employee limit: Up to Rs 2 Lakhs (In certain cases employees are given discount if bidding amount is upto Rs. 2 lakhs) If applying as RII: Upto Rs. 2 lakhs If applying as NII: sNII > Rs. 2 lakhs and upto Rs. 10 lakhs and bNII > Rs. 10 lakhs",
          "Yes for Employee and RII/NII"
        ]
      ]
    },
    {
      "heading": "Senores Pharmaceuticals Limited Financial Information (Restated Consolidated)",
      "sanitizedHeading": "financials",
      "headers": [
        "Period Ended",
        "30 Sep 2024",
        "31 Mar 2024",
        "31 Mar 2023",
        "31 Mar 2022"
      ],
      "rows": [
        [
          "Assets",
          "678.08",
          "621.88",
          "131.05",
          "59.15"
        ],
        [
          "Revenue",
          "183.35",
          "217.34",
          "39.02",
          "14.63"
        ],
        [
          "Profit After Tax",
          "23.94",
          "32.71",
          "8.43",
          "0.99"
        ],
        [
          "Net Worth",
          "319.06",
          "231.71",
          "45.5",
          "36.59"
        ],
        [
          "Reserves and Surplus",
          "263.36",
          "175.94",
          "35.25",
          "25.37"
        ],
        [
          "Total Borrowing",
          "242.03",
          "248.38",
          "60.76",
          "14.21"
        ]
      ]
    },
    {
      "heading": "Senores Pharmaceuticals Limited Stock Quote & Charts",
      "sanitizedHeading": "senores_pharmaceuticals_stock_quote_charts",
      "headers": [
        "KPI",
        "Values"
      ],
      "rows": [
        [
          "ROE",
          "23.60%"
        ],
        [
          "ROCE",
          "11.73%"
        ],
        [
          "Debt/Equity",
          "1.07"
        ],
        [
          "RoNW",
          "23.60%"
        ],
        [
          "PAT Margin",
          "15.25"
        ],
        [
          "Price to Book Value",
          "5.84"
        ]
      ]
    },
    {
      "heading": "Senores Pharmaceuticals Limited Stock Quote & Charts",
      "sanitizedHeading": "senores_pharmaceuticals_stock_quote_charts",
      "headers": [
        null,
        "Pre IPO",
        "Post IPO"
      ],
      "rows": [
        [
          "EPS (Rs)",
          "9.83",
          "13.86"
        ],
        [
          "P/E (x)",
          "39.77",
          "28.21"
        ]
      ]
    }
  ],
  "anchorInvestors": {
    "summary": "Senores Pharmaceuticals IPO raises Rs 260.63 crore from anchor investors. Senores Pharmaceuticals IPO Anchor bid date is December 19 2024. Senores Pharmaceuticals IPO Anchor Investors list",
    "list_link": {
      "text": "Senores Pharmaceuticals IPO Anchor Investors list",
      "url": "https://www.chittorgarh.net/reports/anchor-investor/senores_anchorallocationreport.pdf"
    },
    "details": {
      "ipo_date": "March 25 2025",
      "shares_offered": "6665725",
      "anchor_portion_size": "260.63"
    }
  },
  "basicDetails": {
    "ipoDate": "December 20, 2024 to December 24, 2024",
    "ipoListingDate": "Mon, Dec 30, 2024",
    "faceValue": "₹10 per share",
    "issuePrice": "₹391.00",
    "lotSize": "38 Shares",
    "issueSize": "1,48,87,723 shares (aggregating up to ₹582.11 Cr)",
    "freshIssue": "1,27,87,723 shares (aggregating up to ₹500.00 Cr)",
    "offerForSale": "21,00,000 shares of ₹10 (aggregating up to ₹82.11 Cr)",
    "issueType": "Bookbuilding IPO",
    "listingAt": "BSE, NSE",
    "ipoOpenDate": "Fri, Dec 20, 2024",
    "ipoCloseDate": "Tue, Dec 24, 2024",
    "initiationOfRefunds": "Fri, Dec 27, 2024",
    "creditOfSharesToDemat": "Fri, Dec 27, 2024",
    "shareHoldingPreIssue": "3,32,65,865 shares",
    "shareHoldingPreIssueAll": [
      {
        "label": "Share Holding Pre Issue",
        "value": "3,32,65,865 shares"
      },
      {
        "label": "Share Holding Pre Issue",
        "value": "71.10%"
      }
    ],
    "shareHoldingPostIssue": "4,60,53,588 shares",
    "shareHoldingPostIssueAll": [
      {
        "label": "Share Holding Post Issue",
        "value": "4,60,53,588 shares"
      },
      {
        "label": "Share Holding Post Issue",
        "value": "45.77%"
      }
    ]
  },
  "closing_date": "2024-12-23T18:30:00.000Z",
  "contactDetails": {
    "phone": "+91-79-29999857",
    "email": "cs@senorespharma.com",
    "full_address": "Senores Pharmaceuticals Limited, 1101 to 1103 11th floor, South Tower ONE 42 oppositeJayantilal Park, Ambali Bopal Road Ahmedabad-380054",
    "website": "https://senorespharma.com/"
  },
  "createdAt": "2025-04-18T12:48:01.495Z",
  "faqs": [
    {
      "question": "What is the Senores Pharmaceuticals IPO?",
      "answer": "<div itemprop=\"text\"><p>Senores Pharmaceuticals IPO<!-- --> is a <b>main-board<!-- --> <!-- -->IPO<!-- --> of <!-- -->14887723<!-- --> equity shares</b> of the face value of ₹<!-- -->10<!-- --> aggregating up to ₹<!-- -->582.11<!-- --> Crores. The issue is priced at <span>₹391 per share</span>. The minimum order quantity is <!-- -->38<!-- -->.</p><p>The <!-- -->IPO<!-- --> <b>opens on <!-- -->December 20, 2024</b>, and <b>closes on <!-- -->December 24, 2024</b>.</p><p>Link Intime India Private Ltd<!-- --> is the registrar for the <!-- -->IPO<!-- -->. The shares are proposed to be listed on <!-- -->BSE, NSE<!-- -->.</p></div>"
    },
    {
      "question": "How to apply in Senores Pharmaceuticals IPO through Zerodha?",
      "answer": "<div itemprop=\"text\"><p>Zerodha customers can apply online in <!-- -->Senores Pharmaceuticals IPO<!-- --> using UPI as a payment gateway. Zerodha customers can apply in <!-- -->Senores Pharmaceuticals IPO<!-- --> by login into Zerodha Console (back office) and submitting an IPO application form.</p><p><strong>Steps to apply in <!-- -->Senores Pharmaceuticals IPO<!-- --> through Zerodha</strong></p><ol><li>Visit the Zerodha website and login to Console.</li><li>Go to Portfolio and click the IPOs link.</li><li>Go to the '<!-- -->Senores Pharmaceuticals IPO<!-- -->' row and click the 'Bid' button.</li><li>Enter your UPI ID, Quantity, and Price.</li><li>Submit IPO application form.</li><li>Visit the UPI App (net banking or BHIM) to approve the mandate.</li></ol><p>Visit <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Application Process Review\">Zerodha IPO Application Process Review</a> for more detail.</p></div>"
    },
    {
      "question": "When Senores Pharmaceuticals IPO will open?",
      "answer": "<div itemprop=\"text\"><p>The Senores Pharmaceuticals IPO opens on December 20, 2024 and closes on December 24, 2024.</p></div>"
    },
    {
      "question": "What is the lot size of Senores Pharmaceuticals IPO?",
      "answer": "<div itemprop=\"text\"><p>Senores Pharmaceuticals IPO<!-- --> <b>lot size is <!-- -->38</b>, and the <b>minimum amount required is <span>₹14,858</span></b>.</p></div>"
    },
    {
      "question": "How to apply for Senores Pharmaceuticals IPO?",
      "answer": "<div itemprop=\"text\"><p>You can apply in <!-- -->Senores Pharmaceuticals IPO<!-- --> online using either <a href=\"/article/upi-payment-option-ipo-application-explained/382/\">UPI</a> or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Review\"><b>Zerodha</b></a>, <a href=\"/broker/upstox/ipo/33/\" title=\"Upstox IPO Review\">Upstox</a>, <a href=\"/broker/5paisa/ipo/4/\" title=\"5Paisa IPO Review\">5Paisa</a>, <a href=\"/broker/edelweiss_broking/ipo/34/\" title=\"Nuvama IPO Review\">Nuvama</a>, <a href=\"/broker/hdfc-securities/ipo/6/\" title=\"HDFC Bank IPO Review\">HDFC Bank</a>, and <a href=\"/broker/sbi-capital/ipo/19/\" title=\"SBI Capital IPO Review\">SBI Bank</a>.</p></div>"
    },
    {
      "question": "When is Senores Pharmaceuticals IPO allotment?",
      "answer": "<div itemprop=\"text\"><p>The finalization of Basis of Allotment for <!-- -->Senores Pharmaceuticals IPO<!-- --> will be done on <!-- -->Thursday, December 26, 2024<!-- -->, and the allotted shares will be credited to your demat account by <!-- -->Friday, December 27, 2024<!-- -->. Check the <a href=\"/ipo_allotment_status/senores-pharmaceuticals-ipo/1943/\" title=\"Senores Pharmaceuticals IPO Allotment Status\">Senores Pharmaceuticals IPO<!-- --> allotment status</a>.</p></div>"
    },
    {
      "question": "When is Senores Pharmaceuticals IPO listing date?",
      "answer": "<div itemprop=\"text\"><p>The <!-- -->Senores Pharmaceuticals IPO<!-- --> listing date is on <b>Monday, December 30, 2024</b>.</p></div>"
    }
  ],
  "ipoName": "Senores Pharmaceuticals",
  "issue_price": "₹391.00",
  "issue_price_numeric": 391,
  "issue_size": "1,48,87,723 shares (aggregating up to ₹582.11 Cr)",
  "issue_size_numeric": 1,
  "leadManagerReports": [
    {
      "text": "IPO Lead Manager Performance Summary",
      "url": "/report/ipo_lead_manager_performance_tracker/19/"
    },
    {
      "text": "IPO Lead Manager Performance Tracker",
      "url": "/report/ipo-lead-manager-vs-listing-gain/99/17/"
    }
  ],
  "leadManagers": [
    {
      "name": "Equirus Capital Private Limited",
      "url": "/report/ipo-lead-manager-review/112/133/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/133/"
    },
    {
      "name": "Ambit Private Limited",
      "url": "/report/ipo-lead-manager-review/112/119/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/119/"
    },
    {
      "name": "Nuvama Wealth Management Limited",
      "url": "/report/ipo-lead-manager-review/112/408/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/408/"
    }
  ],
  "listingDayTrading": {
    "data": {
      "final_issue_price": {
        "bse": "391.00"
      },
      "open": {
        "bse": "593.70"
      },
      "low": {
        "bse": "538.85"
      },
      "high": {
        "bse": "609.00"
      },
      "last_trade": {
        "bse": "557.80"
      }
    },
    "performance_link": {
      "text": "Check IPO Performance…",
      "url": "/ipo/ipo_perf_tracker.asp"
    }
  },
  "listingDetails": {
    "pre_open_links": [
      {
        "text": "Pre-Open Session - NSE",
        "url": "https://www.nseindia.com/market-data/new-stock-exchange-listings-today"
      },
      {
        "text": "Pre-Open Session - BSE",
        "url": "https://www.bseindia.com/eqstreamer/StockTickerSplPreOpen.html"
      }
    ],
    "ipo_date": "December 30 2024",
    "bse_script_code": "544319",
    "nse_symbol": "SENORES",
    "isin": "INE0RB801010",
    "final_issue_price": "391 per share"
  },
  "listing_date": "2024-12-29T18:30:00.000Z",
  "listing_gains": "42.66%",
  "listing_gains_numeric": 42.66,
  "logo": "https://www.chittorgarh.net/images/ipo/senores_logo.png",
  "logo_url": "https://www.chittorgarh.net/images/ipo/senores_logo.png",
  "lotSize": {
    "summary": "Investors can bid for a minimum of 38 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.",
    "applications": {
      "retail_min": {
        "application": "Retail (Min)",
        "lots": "1",
        "shares": "38",
        "amount": "14858"
      },
      "retail_max": {
        "application": "Retail (Max)",
        "lots": "13",
        "shares": "494",
        "amount": "193154"
      },
      "shni_min": {
        "application": "S-HNI (Min)",
        "lots": "14",
        "shares": "532",
        "amount": "208012"
      },
      "shni_max": {
        "application": "S-HNI (Max)",
        "lots": "67",
        "shares": "2546",
        "amount": "995486"
      },
      "bhni_min": {
        "application": "B-HNI (Min)",
        "lots": "68",
        "shares": "2584",
        "amount": "1010344"
      },
      "lot_size": {
        "application": "Lot Size Calculator"
      }
    },
    "calculator_link": {
      "text": "Lot Size Calculator",
      "url": "/ipo-hni-funding-cost-calculator/senores-pharmaceuticals-ipo/1943/"
    }
  },
  "lot_size": 38,
  "opening_date": "2024-12-19T18:30:00.000Z",
  "pageHeading": "Senores Pharmaceuticals Limited IPO (Senores Pharmaceuticals IPO) Detail",
  "pageTitle": "Senores Pharmaceuticals IPO Date, Price, GMP, Details",
  "promoterHolding": {
    "promoters": "The promoters of the company are Swapnil Jatinbhai Shah and Ashokkumar Vijaysinh Barot.",
    "holdings": {
      "share_holding_pre_issue": "71.10%",
      "share_holding_post_issue": "45.77%"
    },
    "note": "The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue"
  },
  "prospectusLinks": [
    {
      "text": "Senores Pharmaceuticals IPO DRHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/jul-2024/senores-pharmaceuticals-limited_85341.html"
    },
    {
      "text": "Senores Pharmaceuticals IPO RHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/dec-2024/senores-pharmaceuticals-limited-rhp_89951.html"
    },
    {
      "text": "Anchor Investors in Senores Pharmaceuticals IPO",
      "url": "https://www.chittorgarh.net/reports/anchor-investor/senores_anchorallocationreport.pdf"
    }
  ],
  "recommendationSummary": {
    "recommendations": {
      "brokersbrokers": {
        "subscribe": "9",
        "neutral": "1",
        "avoid": "0"
      },
      "membersmembers": {
        "subscribe": "0",
        "neutral": "0",
        "avoid": "0"
      }
    },
    "links": [
      {
        "text": "Read All Reviews",
        "url": "/ipo-recommendation/senores-pharmaceuticals-ipo/1943/"
      },
      {
        "text": "Post Your Review",
        "url": "#"
      },
      {
        "text": "Manage Reviews",
        "url": "#"
      }
    ]
  },
  "registrarDetails": {
    "name": "Link Intime India Private Ltd",
    "phone": "+91-22-4918 6270",
    "email": "senorespharma.ipo@linkintime.co.in",
    "website": "https://linkintime.co.in/Initial_Offer/public-issues.html"
  },
  "reservation": {
    "summary": "Senores Pharmaceuticals IPO offers 14812723 shares. 4443817 (30%) to QIB 2221909 (15%) to NII 1481272 (10%) to RII and 6665725 (45%) to Anchor investors.",
    "allocation": [
      {
        "investor_category": "Anchor Investor Shares Offered",
        "shares_offered": "6665725 (45%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "QIB Shares Offered",
        "shares_offered": "4443817 (30%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "NII (HNI) Shares Offered",
        "shares_offered": "2221909 (15%)"
      },
      {
        "investor_category": "bNII > 10L",
        "shares_offered": "1518605 (10.25%)",
        "maximum_allottees": "2854"
      },
      {
        "investor_category": "sNII < 10L",
        "shares_offered": "703304 (4.75%)",
        "maximum_allottees": "1322"
      },
      {
        "investor_category": "Retail Shares Offered",
        "shares_offered": "1481272 (10%)",
        "maximum_allottees": "38980"
      },
      {
        "investor_category": "Total Shares Offered",
        "shares_offered": "14812723 (100%)"
      }
    ]
  },
  "scraped_at": "2025-04-18T12:48:01.494Z",
  "source_url": "",
  "status": "listed",
  "subscriptionStatus": {
    "summary": "The Senores Pharmaceuticals IPO is subscribed 97.86 times on December 24 2024 6:19:11 PM (Day 3). The public issue subscribed 93.16 times in the retail category 97.84 times in the QIB category and 100.35 times in the NII category. Check Day by Day Subscription Details (Live Status)",
    "overall": {
      "qib": {
        "category": "QIB",
        "subscription_times": "97.84",
        "shares_offered": "4443817",
        "shares_bid_for": "434778102"
      },
      "nii": {
        "category": "NII",
        "subscription_times": "100.35",
        "shares_offered": "2221909",
        "shares_bid_for": "222963632"
      },
      "bnii": {
        "category": "bNII (bids above 10L)",
        "subscription_times": "95.25",
        "shares_offered": "1518605",
        "shares_bid_for": "144653764"
      },
      "snii": {
        "category": "sNII (bids below 10L)",
        "subscription_times": "111.35",
        "shares_offered": "703304",
        "shares_bid_for": "78309868"
      },
      "retail": {
        "category": "Retail",
        "subscription_times": "93.16",
        "shares_offered": "1481272",
        "shares_bid_for": "137996126"
      },
      "total": {
        "category": "Total",
        "subscription_times": "97.86",
        "shares_offered": "8146998",
        "shares_bid_for": "797231982"
      }
    },
    "total_applications": "3701011"
  },
  "tentativeDetails": {
    "ipo_date": "5 PM on December 24 2024",
    "tentative_allotment": "Thu Dec 26 2024",
    "initiation_of_refunds": "Fri Dec 27 2024",
    "credit_of_shares_to_demat": "Fri Dec 27 2024"
  },
  "updatedAt": "2025-04-19T04:37:13.010Z",
  "updated_at": "2025-04-18T12:48:01.494Z",
  "year": 2024,
  "worst_listing_gains": "42.66%",
  "worst_listing_gains_numeric": 42.66
}